Neuroscience News

Fat-filled microglia may play a role in the damage caused by Alzheimer’s, especially for those who carry two copies a particular gene.

We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression.

With Knight Initiative support, Stanford researchers uncover a biochemical “off-ramp” in ketosis, rewriting our understanding of how ketosis influences metabolism.

Supported by the Big Ideas in Neuroscience program, research from the Brunet lab suggests the possibility of designing pharmaceutical or genetic therapies to turn on new neuron production in old or injured brains.

Wu Tsai Neuro affiliate Carolyn Rodriguez directs the Stanford OCD Research Lab.

With support from a Wu Tsai Neuro seed grant, faculty affiliate Helen Bronte-Stewart and her team have developed a simple, portable device to help Parkinson'

Research projects funded by the Wu Tsai Neurosciences Institute's Synthetic Neuroscience Grants will advance molecular and tissue engineering tools to more precisely study and interact with brain circuits.

This week on From Our Neurons to Yours, we talk with Stanford neurologist Mike Greicius about his critique of new amyloid-clearing Alzheimer's drugs, and his optimism for the next wave of therapies currently in development.

New research by Institute affiliate Leanne Williams adds to the evidence that choosing treatment based on the neurological underpinnings of a patient’s depre

This week on From Our Neurons to Yours, we talk with Leanne Williams about distinctive biotypes of depression revealed by brain imaging and AI, and the implications for therapy and mental health.

Research by Kati Andreasson and colleagues suggests that a type of drug developed for treating cancer may hold promise as a new treatment for neurodegenerati

A team of neuroscientists at the Knight Initiative for Brain Resilience have zeroed in on a critical regulator of brain metabolism that may be over-activated in the brains of patients with Alzheimer’s disease.

It may feel like you’re being more productive, but experts like Anthony Wagner say you’re not.

Time marches on predictably, but biological aging is anything but constant, according to new research by Michael Snyder and colleagues.

This week on From Our Neurons to Yours, we talk with Michelle Monje about her discovery that many cancers depend on nervous system innervation; she also discusses opportunities for novel therapies.

This week on From Our Neurons to Yours, we talk with Sergiu Pasca about using new techniques for growing human brain tissue in the lab to solve a rare neurological disorder.